Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Stevens

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Chest|August 11, 2012
Reduction of peripherally inserted central catheter-associated DVTR Scott Evans, Jamie H Sharp, Lorraine H Linford, et al.
Chest|October 7, 2010
Risk of symptomatic DVT associated with peripherally inserted central cathetersR Scott Evans, Jamie H Sharp, Lorraine H Linford, et al.
The American Journal of Emergency Medicine|January 3, 2021
Cost-effectiveness of managing low-risk pulmonary embolism patients without hospitalization. The low-risk pulmonary embolism prospective management studyJoseph R Bledsoe, Scott C Woller, Scott M Stevens, et al.
Chest|February 9, 2012
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesShannon M Bates, Roman Jaeschke, Scott M Stevens, et al.
The American Journal of Cardiology|June 28, 2021
Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial FibrillationScott A Rizzi, Stacey Knight, Heidi T May, et al.
Blood Advances|October 18, 2021
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialScott C Woller, Scott M Stevens, David Kaplan, et al.
Circulation|November 9, 2007
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulationJeffrey L Anderson, Benjamin D Horne, Scott M Stevens, et al.
Chest|May 17, 2014
Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolismScott C Woller, Scott M Stevens, Daniel M Adams, et al.
Research and Practice in Thrombosis and Haemostasis|October 15, 2024
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolismScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Journal of the American Heart Association|July 13, 2016
Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other IndicationsT Jared Bunch, Heidi T May, Tami L Bair, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Chest|August 11, 2012
Reduction of peripherally inserted central catheter-associated DVTR Scott Evans, Jamie H Sharp, Lorraine H Linford, et al.
Chest|October 7, 2010
Risk of symptomatic DVT associated with peripherally inserted central cathetersR Scott Evans, Jamie H Sharp, Lorraine H Linford, et al.
The American Journal of Emergency Medicine|January 3, 2021
Cost-effectiveness of managing low-risk pulmonary embolism patients without hospitalization. The low-risk pulmonary embolism prospective management studyJoseph R Bledsoe, Scott C Woller, Scott M Stevens, et al.
Chest|February 9, 2012
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesShannon M Bates, Roman Jaeschke, Scott M Stevens, et al.
The American Journal of Cardiology|June 28, 2021
Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial FibrillationScott A Rizzi, Stacey Knight, Heidi T May, et al.
Blood Advances|October 18, 2021
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialScott C Woller, Scott M Stevens, David Kaplan, et al.
Circulation|November 9, 2007
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulationJeffrey L Anderson, Benjamin D Horne, Scott M Stevens, et al.
Chest|May 17, 2014
Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolismScott C Woller, Scott M Stevens, Daniel M Adams, et al.
Research and Practice in Thrombosis and Haemostasis|October 15, 2024
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolismScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Journal of the American Heart Association|July 13, 2016
Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other IndicationsT Jared Bunch, Heidi T May, Tami L Bair, et al.
Pageof 11